Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies-Reference-Cited by-同舟云学术

Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies

Published:2023-09 Issue: Volume:70 Page:100988
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Jia Wenhui,Huang Zhao,Zhou Li,Liou Yih-Cherng,Di Virgilio Francesco,Ulrich Henning,Illes Peter,Zhang Wei,Huang Canhua,Tang Yong

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference140 articles.

1. Expression of P2×7 receptor increases in vivo tumor growth;Adinolfi;Cancer Res,2012

2. Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation;Adityan;J. Control. Release,2020

3. Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer;Allahyari;Nanomedicine,2021

4. MRI-traceable theranostic nanoparticles for targeted cancer treatment;Anani;Theranostics,2021

5. Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia;Arruga;Haematologica,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: ABC transporters and drug resistance;Drug Resistance Updates;2024-11

2. Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers;Frontiers in Oncology;2024-04-26

3. Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity;Frontiers in Immunology;2024-04-23

4. Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology;Heliyon;2024-03

5. Construction of a Novel Mitochondria-Associated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival;Journal of Microbiology and Biotechnology;2024-02-22